National Alliance for Medication Assisted Recovery

Add Your Name to Advocacy

Similar Posts

  • Letter to the editor

    Admin 10/26/2021

    Letter to the editor RoanokeTimes (in publication) January 3, 2005 Give some credit to methadone treatment. In response to your Dec. 19 news article, “Are drug deaths decreasing?”: I’d like to make an observation. I’m struck that in trying to find an answer as to why the “drug deaths” may be decreasing, there’s a glaring…

  • Drug Policy in the Age of AIDS: The Philosophy of Harm Reduction Rod Sorge

    Admin 03/29/2021

    We have understood HIV transmission for years. The routes are obvious, limited, and modifiable, yet HIV seroprevalence has steadily increased around the world. There have been only limited medical advances in the treatment of HIV-related illness. Because of a lack of federal leadership on all fronts, from funding to discrimination, misguided research priorities at the…

  • |

    Medical Release Print

    Admin 12/11/2022

    AUTHORIZING Patient’s NAME (please print): Last: __________________ First ______________ M.I.___      Date of Birth: ___________________ Social Security #: ______ – _____ – ______ AUTHORIZATION FOR RELEASE OF INFORMATION AND DISCUSSION BETWEEN National Alliance of Methadone Advocates (NAMA) 435 Second Avenue New York, NY 10010 tel/fax: 212 595-6262 AND _____________________________________________  (Person/Facility) ______________________________________________   (Address) ______________________________________________   (Address) ______________________________________________  (City, ST, Zip)…

  • The First Patient Advocate’s Illumination Award Sunday, October 7th

    Admin 12/19/2021

    The First Patient Advocate’s Illumination Award Sunday, October 7th The Advocate’s Illumination Award is presented to an individual and/or treatment program whose persistence in the search of solutions to the myriad problems of addictive disease, has significantly improved the experience and outcome of treatment. Inscription The Opioid Agonist Treatment Advocacy Community with heartfelt thanks and…

  • |

    Statement About MMT from NIDDK

    Admin 04/25/2022

    From NIDDK Fact Sheet Chronic Hepatitis C: Current Disease Management “Strict abstinence from alcohol is recommended during therapy with interferon. Interferon therapy can be associated with relapse in people with a previous history of drug or alcohol abuse. Therefore, alpha interferon should be given with caution to a patient who has only recently stopped alcohol…

  • |

    Quick Links

    Admin 11/28/2022

    Treatment Facility Locator Buprenorphine Physician Locator Center for Substance Abuse Treatment US government search engine to locate all forms of drug treatment. Substance Abuse Mental Health Services Administration (SAMHSA) US government search engine to locate physicians prescribing Buprenorphine. Code of Federal Regulations Federal Register, January 17, 2001   CRF 42 Part 8 in text and…